$NURS.V Current price: 1,51$ Price target: 6,03 $ byronstreetresearch.com Hydreight Technologies Inc. TSXV:NURS; OTCQB:HYDTF; FSE:SO6

Do I see a P/E of 1 for $NURS.V next year?😏

New Write-Up (Finally!) $NURS is a 50-state mobile healthcare and telemedicine company with a clinical network of over 3,000 nurses, more than 200 independent doctors, and a suite of federally regulated pharmacies. Initially launched as an “Uber for nurses,” enabling licensed

ZoomD Technologies ⭐️⭐️⭐️⭐️1/4 FINS Review: $ZOMD.V #2025WolfPick "That is a ridiculous 26% of net income to sales in the quarter." #FinsDontLie

What a beauty, and a big win for many of our subscribers $ZOMD.V

$PPIH with a blowout quarter. Should be $20+ right now with those numbers and the backlog more than doubling since last year this time.

$NURS.V $HYDTF management confirmed in the webinar that some of the D2C’s making up the 150,000 a month order volume started migrating those orders onto VSDHOne at the beginning of June. If all goes well, those orders will be moved over by the end of July. Fingers crossed.

$PPIH doing very well today in the market. Company will do over $2+ EPS the next 12 months, which puts it at an 11-12 P/E. Growth will accelerate as the backlog continues to grow. The Middle East is spending billions of dollars every year on infrastructure projects. New CEO

A Sample of VSDHOne Clients If $NURS achieves even a fraction of its 1.3mm order goal, say, 250k orders, it would still translate to 200%+ growth in 2H25 (~10x Q4 run-rate EPS). We’ve been able to identify ~450 licensees out of the ~600 that are reportedly already sold. Many of

Coming Soon? Confirmed! $NURS.V

$NURS – Here’s why I think the company will post 100%+ YoY revenue growth in Q3: I believe their core business can grow 25–40% annually, but let’s start with what didn’t exist in Q3 2024 — their “Shopify for Telehealth” platform: VSDHOne.

Deal announcement 🚨: $NURS.V / $HYDTF announced today that it has entered into a strategic partnership with Texas-based Perfect Scripts LLC. Perfect Scripts LLC is the parent company to PerfectRx. The company currently owns a 503A retail dispensing mail order pharmacy (no

Yday, $NURS.V agreed to acquire an initial 5% stake in Perfect Scripts in exchange for 2.25mm shares. As part of the agreement, they will partner to launch a 503B pharmacy, and Hydreight will receive the lowest pricing on all products sold or made available by Perfect Scripts.

$NURS.V $HYDTF confirmed they are receiving 35,000 - 70,000 orders in July. They are now getting 2,000 orders a day! They are expecting to see 4,000-5,000 orders a day in August! They expect to see margins going to 20% range in August as well. Absolutely mindblowing!

$NURS.V - context: at August order run rate & margin => over 100m revenue, over 100% growth PE: 4x. Ramping to December run rate => 1x PE. There are risks (compliance / GLP1 / dilution) but think very assymetric trade, with multi bagger potential. Reminds me of $ZOMD a year ago.

Thank you, Maj, for sharing this conversation with subscribers! This conversation happened a day before Hydreight’s webinar. In that webinar, management disclosed it is now processing 2,000 orders a day. That will likely be 5,000 a day by the start of August. $NURS.V $HYDTF

$NURS.V $HYDTF For those who missed the webinar: youtu.be/_oOksk9A5Ms?si…

drfranks.com $NURS.V $HYDTF Dr Frank’s is officially online.

Maxim eröffnet die Coverage von $NURS.V Hydreight Technologies mit einem Buy Rating und Kursziel von C$8. Das Unternehmen will den Zugang zur Gesundheitsversorgung über sein „Uber“-ähnliches Pflegenetzwerk erweitern, um Dienstleistungen an jedem Ort anzubieten, so der Analyst in

Maxim group with a very conservative $8 PT on $NURS.V $NURS $HYDTF